25 Years of SBRT with CyberKnife

Dr. Anand Mahadevan is the Professor and Chairman of Radiation Oncology and Dr. Jimm Grimm is the Lead CyberKnife Physicist at Geisinger Medical Center.

Glioblastoma re-irradiation with the CyberKnife® System

“Because most patients with glioblastoma (GBM) will recur, mainly within the first radiation therapy (RT) volume, consequently the question of re-RT, post or instead of reoperation, is critical in our daily practice. As there is no standard in this situation of first recurrence, it seems relevant to share and exchange with the neuro-oncologic community about our 10-year experience of GBM re-irradiation, with and without concomitant Bevacizumab, particularly with the CyberKnife system, which holds in our opinion a very unique place.”

Tips and Tricks to Treat Central Lung Tumors with the CyberKnife® System

Dr. Nuyttens will share his 15 years of experience in treating lung lesions with the CyberKnife System. He will focus on how effectively central lung tumors can be treated, the challenges faced and how he manages to deliver the most effective dose. Dr. Nuyttens will show actual cases, planning, dose constraints and clinical outcomes.

TomoTherapy® for Breast Cancer in a Clinical Practice

In this webinar we will present both clinical and technical aspects of our hypofractationed approach to whole breast, partial breast and breast reirradation using TomoTherapy®. We will describe how we select patient for TomoDirect™ and TomoHelical™ modalities, and will share details of our Phase I/II clinical trial on single fraction ablative preoperative radiation treatment for early-stage breast cancer.

Russian Experience of using Helical TomoTherapy for Total Body Irradiation in Wide Heterogenic Cohort of 262 Pediatric Patients with Hematological Malignancies

Dmitry Rogachev National Research Center in Russia is a leading specialized center in the area of pediatric hematology/oncology and immunology. In this webinar we will share our experience with Helical TomoTherapy for the application of Total Body Irradiation in a wide heterogenic cohort of pediatric patients with hematological malignancies. We have treated 262 pediatric patients since this approach was introduced in our center in 2014.

Clinical Results After Single-fraction Radiosurgery for 1,002 Vestibular Schwannomas

Prof. Alexander Muacevic is the medical director of the European CyberKnife Center in Munich, Germany. He holds an academic teaching position at the University of Munich Hospitals. His main clinical and scientific interest is full body radiosurgery using advanced image-guided robotic technology. He is a trained and board certified neurosurgeon and radiosurgeon. In addition, he holds a European Neurosurgery Certificate. He has published over 100 scientific contributions such as full papers, book chapters and congress proceedings. Alexander Muacevic is member of several academic societies and the president of the International Radiosurgery Society which has over 700 members. He is co-founder and the co-chief editor of Cureus.com.